5月19日,诺瓦瓦克斯医药美股在盘前交易中上涨近19%。此次涨幅源于美国食品药品监督管理局(FDA)对其疫苗的有条件批准,此举或将推动公司业务进一步发展。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.